BOT 2.50% 4.1¢ botanix pharmaceuticals ltd

Thought I would remind people who aren't exactly sure of the...

  1. 2,192 Posts.
    lightbulb Created with Sketch. 119
    Thought I would remind people who aren't exactly sure of the current situation and what we have coming up to make this a very exciting 2020. Trying to illustrate just how low this SP is and what a great opportunity you have to buy in now at these low prices, if your still considering whether to or not.

    : Price got to a high of 27c in September in anticipation of great results for our acne treatment Btx1503, which based on the AUS results we did!

    : The company is investigating into why there was a separation between the AUS and US trials in the phase 2 acne trial and we will know the reasons why soon.

    : The company will gain approval from the FDA because the trial for BTX1503 was statistically one of the safest acne trials ever to occur through FDA

    : The announcement they made on BTX1503 was difficult to understand and they have apparently learned from this and will word future announcements much more clearer and in more layman terms.

    : IMO BOT will look to gain a partner to take us to phase 3 which will eliminate the need to raise capital.

    : Botanix also has an anti-microbial study in its pipeline which is potentially the most important product that the company is developing given that this targets bacterial infections such as golden staph which is high up on the list of the biggest killers in hospitals every year. Earlier in the year when BOT released an announcement on the anti-microbial product, the SP went from 11-12c into the 20c price range.

    : We have 7mill in the bank and waiting on a R&D rebate of around 3mill.

    : Atopic Dermatitis trial has started 12 months ago we will have the results around Feb end-March. The Atopic dermatitis trial is a different formulation to what was used on acne patients in phase 2 and the company anticipates a much lower placebo response. BIG PLUS!

    : BOT are also about to start phase 1 rosacea trial with an estimated readout in Q2 CY2020.

    So just some points on what we have coming up and IMO what a fantastic opportunity we have to make some money. it would not be unfathomable to think we could be near that $1 mark by the end of Q1- or is that just dreaming based on the above????
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Mkt cap ! $39.88M
Open High Low Value Volume
3.9¢ 4.4¢ 3.8¢ $352.0K 8.498M

Buyers (Bids)

No. Vol. Price($)
5 688695 4.1¢

Sellers (Offers)

Price($) Vol. No.
4.3¢ 88461 2
View Market Depth
Last trade - 16.10pm 08/04/2020 (20 minute delay) ?
0.001 ( 12.5 %)
Open High Low Volume
3.8¢ 4.4¢ 3.8¢ 3301084
Last updated 15.20pm 08/04/2020 (live) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.